Solid Biosciences presents gene therapy research at Hamburg congress
What happened
Solid Biosciences Inc. announced that seven abstracts were accepted for poster presentation at the 33rd European Society of Gene & Cell Therapy (ESGCT) Annual Congress in Hamburg, Germany. The accepted research spans multiple areas of gene therapy, including therapeutic design, capsid engineering, and manufacturing. These presentations include studies supporting Solid's investigational Duchenne muscular dystrophy program.
From manilatimes.net
Why it matters
The accepted abstracts detail research focused on precision genetic medicines, such as the evaluation of Solid's next-generation POLARIS-101™ capsid platform. This progress highlights advancements in the development of gene therapy for neuromuscular and cardiac diseases.
From manilatimes.net
Who's involved
Keep exploring
The entities involved
-
Hamburg
city and state in the North of Germany
- The global bunker fuel market is showing mixed signals, with availability tight in Gibraltar and operational status reported from key hubs like Hamburg and Danish waters.
- Investigators tracked a yacht from Rostock to Bornholm, leading to an arrest warrant in Germany and extradition approval from Italy.
-
SOLID
Czech company
Nothing else this week.